Aethlon Medical corrects 8-K: proposal to authorize 20M preferred shares failed at annual meeting

AETHLON MEDICAL INC

Proposal No. 7 received 204,122 votes for, 9,529 against, 1,555 abstentions and 184,547 broker non-votes.
Approval required a majority of the 711,136 shares outstanding on the Aug 10, 2026 record date, or at least 355,569 affirmative votes; only 204,122 were cast in favor.
The Articles of Incorporation were not amended and no preferred stock was authorized; the original Oct 1, 2026 Form 8-K had incorrectly reported approval.
The failed amendment would have authorized 20,000,000 preferred shares, $0.001 par value, and let the Board set series terms, powers and preferences.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.